Jay Formulations Ltd - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U17119GJ1988PLC010855 Incorporated 15 June 1988 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2021
₹138.71 Cr
▲ 11% YoY
Net loss · FY 2021
₹27.22 Cr
Net margin -19.6%
EBITDA · FY 2021
-₹17.12 Cr
EBITDA margin -12.3%
Authorised capital
₹3.05 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹73.81 Cr
Satisfied ₹13 Lakh
Company age
38 yrs
Est. 1988
Directors on board
3
As per MCA filings

About Jay Formulations Ltd

Data last updated:

Jay Formulations Ltd is a public limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 June 1988 and has been in existence for over 38 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U17119GJ1988PLC010855. Its GSTIN is 24AAACJ3799G1ZF (Gujarat).

The company has an authorised share capital of ₹3.05 Cr and a paid-up capital of ₹2 Cr. It was formerly known as Bhavik Textiles Pvt Ltd. It is led by directors including Hemant Bhogilal Mehta and Hitendra Nihalchand Mehta.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 13 First Floor Harikrishnacomplex B/H Dipalee Cinema Ashram Road, Ahmedabad, Gujarat, India – 380009.

As per the financials filed for FY 2021, the company reported a revenue of ₹138.71 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹27.22 Cr (net margin -19.6%) and EBITDA of -₹17.12 Cr (EBITDA margin -12.3%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 16% over five years.

As per MCA filings, the company has open charges of ₹73.81 Cr and satisfied charges of ₹13 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jayformulations.in.

Company Details of Jay Formulations Ltd
CIN U17119GJ1988PLC010855
Registration Number 010855
Incorporation Date 15 June 1988
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    13 First Floor Harikrishnacomplex B/H Dipalee Cinema Ashram Road, Ahmedabad, Gujarat, India – 380009
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Jay Formulations Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Jay Formulations Ltd report

Financials, compliance, directors, charges, ownership and filings for Jay Formulations Ltd in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Jay Formulations Ltd

The main business activity of Jay Formulations is manufacturing. In detail, this covers computer, electronic, communication and scientific measuring & control equipment.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC9Computer, electronic, Communication and scientific measuring & control equipmentLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Jay Formulations Ltd

Jay Formulations Ltd is audited by Nimesh Hariya & Associates for the financial year 2021.

NameStatusAppointment DateCessation Date
Nimesh Hariya & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Jay Formulations Ltd

Jay Formulations has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Hemant Bhogilal MehtaAdditional Director05 May 20251 Years 5 MonthsCurrent
Hitendra Nihalchand MehtaAdditional Director05 May 20251 Years 5 MonthsCurrent
Darshan Bhogilal MehtaAdditional Director05 May 20251 Years 5 MonthsCurrent

Financials of Jay Formulations Ltd FY 2024 filings available

Jay Formulations Ltd reported revenue of ₹138.71 Cr (up 11% YoY) for FY 2021.

Revenue · FY 2021
₹138.71 Cr ▲ 11%
Net loss · FY 2021
₹27.22 Cr margin -19.6%
EBITDA · FY 2021
-₹17.12 Cr margin -12.3%

Compounded Annual Growth Rate (CAGR) of Jay Formulations Ltd

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 21%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▼ 327%
3 years · compounded
▼ 83%
5 years · compounded
▼ 47%

Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 11% growth in the latest year. EBITDA fell 327% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Jay Formulations Ltd

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue₹138.71 Cr••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹17.12 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹27.22 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Jay Formulations Ltd

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin-12.3%••••••••••••••••
Net Profit Margin-19.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Jay Formulations are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Jay Formulations Ltd

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Jay Formulations Ltd

Open charges
₹73.81 Cr
Satisfied charges
₹13 Lakh
Breakdown by lending institutions
State Bank of India₹63.00 Cr
Sidbi₹7.80 Cr
Tata Capital Financial Services Limited₹1.24 Cr
The State Bank of India₹0.89 Cr
Others₹0.88 Cr
Latest charge details
DateLenderAmountStatus
08 Jan 2021Sidbi₹2.8 CrOpen
02 Jan 2021Tata Capital Financial Services Limited₹1.24 CrOpen
08 Sep 2020Others₹12.5 LakhOpen
30 Jul 2020Others₹12.39 LakhOpen
24 Jul 2020Sidbi₹2.8 CrOpen

Total charge records: 15 View all charges

Employees and EPFO Compliance at Jay Formulations Ltd

Employment history and EPFO contributions of people linked to Jay Formulations.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Jay Formulations Ltd

Jay Formulations has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAACJ3799G1ZFGujaratActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Jay Formulations Ltd

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Jay Formulations Ltd

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Jay Formulations Ltd

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Jay Formulations Ltd

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Jay Formulations Ltd

Directors
05 May 2025
Hemant Bhogilal Mehta was appointed as a Additional Director on 05 May 2025 & has been associated with this company since 1 year 5 months.
Directors
05 May 2025
Hitendra Nihalchand Mehta was appointed as a Additional Director on 05 May 2025 & has been associated with this company since 1 year 5 months.
Directors
05 May 2025
Darshan Bhogilal Mehta was appointed as a Additional Director on 05 May 2025 & has been associated with this company since 1 year 5 months.
Activity
30 Sep 2024
Jay Formulations Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Jay Formulations Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
08 Jan 2021
A charge with Sidbi amounted to Rs. 2.80 Cr with Charge ID 100406695 was registered on 08 Jan 2021.

Frequently Asked Questions about Jay Formulations Ltd

Jay Formulations is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 June 1988 (38+ years old) and is registered under CIN U17119GJ1988PLC010855.

Jay Formulations reported revenue of ₹138.71 Cr for FY 2021 (up 11% YoY).

Jay Formulations has 3 current directors:

Jay Formulations reported a net loss of ₹27.22 Cr (net margin -19.6%) and EBITDA of -₹17.12 Cr (EBITDA margin -12.3%) for FY 2021, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Jay Formulations is 21% over three years and 16% over five years. In the latest year (FY 2021) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Jay Formulations is 24AAACJ3799G1ZF, registered in Gujarat.

The CIN (Corporate Identification Number) of Jay Formulations is U17119GJ1988PLC010855. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Jay Formulations was incorporated on 15 June 1988, making it 38+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Jay Formulations can be reached through the website jayformulations.in. Its registered office is in Ahmedabad, Gujarat, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available